In a groundbreaking study published in the Journal of Perinatology in May 2026, researchers have uncovered compelling evidence linking early growth trajectories in extremely preterm infants with their subsequent neurodevelopmental performance at the age of three. This study, led by Maeda, Tanahashi, and Asada, offers a pivotal advancement in neonatal care and developmental neuroscience by correlating postnatal anthropometric measures—essentially the physical growth markers—by the term-equivalent age, with neurocognitive abilities later in early childhood. This novel insight holds the promise of transforming prognostic assessments and therapeutic interventions for one of the most vulnerable populations in neonatal intensive care units.
Extremely preterm infants, defined as those born before 28 weeks of gestation, face significant risks of neurodevelopmental impairment due to the interference of early birth with critical stages of brain and bodily growth. The study builds on a body of research emphasizing that, despite advances in neonatal intensive care, these infants exhibit considerable heterogeneity in outcomes, which necessitates precise predictive factors. The authors meticulously measured postnatal growth parameters such as weight, length, and head circumference at specific time points through term-equivalent age, aiming to discern which of these metrics might best serve as indicators of later high-level neurodevelopmental function.
This research taps into the broader context of developmental plasticity—a concept describing the brain’s remarkable capacity to reorganize in response to environmental and physiological stimuli during early life. While preterm birth disrupts normal developmental trajectories, the degree to which growth in the neonatal period can promote or hinder long-term neurodevelopment remains underexplored. The study hypothesizes that robust physical growth during the critical period before reaching term-equivalent age might be associated with optimal brain development and enhanced neurocognitive outcomes, a prospect that, if validated, could inform clinical approaches from the earliest days of postnatal care.
A cohort of extremely preterm infants was longitudinally observed, with precise anthropometric data collected at birth, weekly during hospitalization, and at term-equivalent age. Neurodevelopmental assessments were conducted when the children reached three years, employing standardized cognitive and motor performance scales that measure domains such as language, executive functions, and psychomotor skills. Notably, the study’s design accounted for confounders including gestational age variability, medical complications, and socioeconomic factors, ensuring that the analysis isolated the impact of growth dynamics on neurodevelopment as accurately as possible.
The findings revealed that infants demonstrating greater increments in weight and head circumference by term-equivalent age exhibited significantly improved neurodevelopmental scores at three years. Particularly, head circumference growth—a proxy for brain volume and cerebral maturation—emerged as a critical predictor. These observations underscore the profound interconnectedness between somatic growth parameters and brain development, reinforcing the hypothesis that enhanced postnatal growth could be leveraged as a biomarker for neurodevelopmental prognosis in this high-risk population.
Moreover, the authors emphasized that the quality of growth—not just the quantity—matters profoundly. Rapid weight gain solely skewed towards adiposity without commensurate increases in lean mass or head growth was not associated with the same positive outcomes, highlighting the nuanced interplay between different growth components. This insight challenges simplistic views on neonatal nutrition and advocates for carefully tailored nutritional strategies aimed at supporting balanced growth conducive to optimal cerebral development.
The study also delves into mechanistic hypotheses explaining the link between anthropometric growth and brain development. One avenue proposes that accelerated growth reflects enhanced nutritional status and metabolic support for the rapidly developing neural tissue. Nutrients such as long-chain polyunsaturated fatty acids, iron, and protein play crucial roles in neurogenesis and synaptogenesis; thus, their adequate provision during the neonatal intensive care period could drive the observed improvements in head circumference and subsequent cognitive functions.
Importantly, the implications extend into clinical practice, suggesting that rigorous monitoring of anthropometric growth could serve as a non-invasive, cost-effective, and timely indicator for clinicians to identify infants who may benefit from intensified developmental support. Implementing growth-centered surveillance protocols can facilitate early interventions, such as specialized nutrition programs and neurodevelopmental therapies, ultimately improving long-term outcomes for preterm infants who historically face heightened risks of motor, cognitive, and behavioral impairments.
In dissecting the nuances of postnatal growth trajectories, this study also opens new avenues for personalized medicine approaches in neonatology. By creating growth profiles that predict neurodevelopmental performance, healthcare providers can tailor follow-up schedules, therapeutic regimens, and parental counseling to the needs of each infant, optimizing resource allocation and enhancing family-centered care. This forward-thinking approach harmonizes with the growing trend toward precision health models that emphasize individual variability rather than uniform treatment protocols.
Furthermore, the research correlates with emerging technologies such as advanced neuroimaging and genetic profiling, which may soon complement anthropometric data to create multifaceted predictive models. As our understanding of molecular factors underpinning brain growth deepens, integrating physical growth measures with biological markers could revolutionize the screening and management paradigms for preterm infants, guiding interventions that minimize neurodevelopmental setbacks.
The study’s authors acknowledge limitations inherent in observational research, including potential residual confounding and the need for replication in diverse populations. Nonetheless, the robust sample size, stringent methodological framework, and the longitudinal design lend high credibility to the conclusions. Future research directions highlighted include exploring causality through interventional studies, dissecting the role of specific nutrients and metabolic pathways in mediating growth-linked neurodevelopment, and extending follow-up assessments into later childhood to elucidate the persistence of these early associations.
In sum, this substantial contribution to the field marks a paradigm shift by positioning postnatal anthropometric growth as a key determinant—and potentially a modifiable factor—in the neurodevelopmental trajectories of extremely preterm infants. It emphasizes the compelling necessity for neonatal care teams to prioritize not only survival but also quality and functional outcomes by fostering optimal growth conditions during this sensitive window. The findings herald a future where early-life growth metrics could be instrumental biomarkers, guiding the clinical roadmap toward healthy brain development in a population previously defined by high risk and uncertainty.
This research continues the inspiring momentum in neonatology aimed at narrowing the gap between survival and thriving among the tiniest patients. It calls for integrated approaches that blend nutrition science, developmental neurology, and meticulous clinical monitoring to unlock the fullest potential of human development starting from the very earliest stages of life. As we decode the complex interrelations between body growth and brain function, we edge closer to ensuring that every preterm infant not only survives but flourishes with a quality of life profoundly enriched by this knowledge.
The clarity achieved in this investigation paves the way for vital policy considerations, urging neonatal units worldwide to enhance protocols that emphasize growth tracking as a standard of care. With increasing global preterm birth rates, these findings carry significant public health implications, emphasizing that investments in early growth optimization strategies can yield dividends in cognitive and physical capacities, reducing lifelong disabilities and societal burdens.
In closing, the study by Maeda and colleagues stands as a beacon of scientific progress, illuminating how simple, routinely accessible measurements can unravel the complexities of neurodevelopment in high-risk infants. Their work reinforces that growth is not merely a physical phenomenon but an intricate indicator of brain health and developmental potential, underscoring the extraordinary interconnectedness inherent in human biology and the promise of targeted early-life interventions.
Subject of Research:
The relationship between postnatal anthropometric growth by term-equivalent age and neurodevelopmental outcomes at age three in extremely preterm infants.
Article Title:
Association between postnatal anthropometric growth by term and high-performing neurodevelopment at age 3 years in extremely preterm infants.
Article References:
Maeda, T., Tanahashi, Y., Asada, H. et al. Association between postnatal anthropometric growth by term and high-performing neurodevelopment at age 3 years in extremely preterm infants. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02692-z
Image Credits:
AI Generated
DOI:
13 May 2026
